Physician Perspectives 2017 Use of ustekinumab in IBD Report Updated 01022018 Prices from USD $2500

Physician Perspectives 2017 Use of ustekinumab in IBDSummaryThis Physician Perspectives survey focuses on the use of ustekinumab in IBD.UST appears to be the preferred nonTNF biologic for treatment of moderatetosevere Crohn's disease most frequently prescr...